Bajaj Healthcare Fund Regular Growth is a Sector - Healthcare mutual fund scheme from Bajaj Asset Management Limited. The fund was launched on 27 December 2024 and is managed by Bharat Hegde, Vinay Bafna, and Siddharth Chaudhary. As of 15 October 2026, the fund has an AUM of ₹405.14 Cr and its latest NAV is ₹11.04. The fund has a Very High Risk risk rating.
The fund allows minimum SIP of ₹500 and lumpsum investment starting from ₹500.
The fund primarily invests in Healthcare, Basic Materials, and Consumer Defensive and its top holdings include Divi's Laboratories Ltd, Sun Pharmaceuticals Industries Ltd, Piramal Pharma Ltd, Rubicon Research Ltd, and Aurobindo Pharma Ltd. The fund has delivered 13.1% returns over the last 1 year and 5.9% annualised returns since inception.
Bajaj Healthcare Fund Regular Growth may be suitable for investors looking for Sector - Healthcare and who are comfortable with Very High Risk risk.






